Pular para o conteúdo
Menu
Mix Vale

Ozempic and Wegovy: new advantages for women’s health outweigh weight loss and diabetes

Jeronimo Santos
Por 2 min de leitura
Compartilhe
Ozempic
Foto: Ozempic - Foto: Marc Bruxelle / Shutterstock.com

Semaglutide-based medications, such as Ozempic and Wegovy, have demonstrated beneficial impacts that go far beyond simple weight loss and blood sugar control, presenting especially promising results for women’s health. Although originally designed to treat type 2 diabetes and overweight, these drugs in the GLP-1 agonist class are increasingly being used to manage metabolic and hormonal conditions that are quite common among women.

Publicidade

The use of these treatments has shown a considerable impact on the management of Polycystic Ovary Syndrome (PCOS), a condition characterized by insulin resistance, irregular menstrual cycles and difficulties conceiving. By restoring insulin sensitivity and reducing body fat, semaglutide works to reduce the excessive production of androgens, male hormones that often cause acne, hair loss and unwanted hair in women affected by PCOS.

obesity
obesity – tomjenjira/Shutterstock.com

Another important consequence observed is the spontaneous resumption of ovulation in patients with fertility challenges, often related to obesity or PCOS itself. Doctors and specialists have noticed an increase in pregnancies among women using these medications. However, this observation requires extra caution, as treatment with semaglutide must be stopped immediately in case of confirmed pregnancy, due to the risk of complications in fetal development.

Publicidade

In the context of heart health, studies indicate that Wegovy can reduce the risk of serious cardiovascular events, such as heart attacks and strokes, by up to 20%. This information is of great value to women in the post-menopausal phase, a period in which the decrease in estrogen levels significantly increases the predisposition to heart problems.

The use of semaglutide also requires strict medical monitoring, especially in relation to its interaction with oral contraceptives and possible changes in the menstrual cycle. The process of delayed gastric emptying, caused by the medication, can influence the absorption of other medications administered orally, requiring specialized guidance to prevent contraceptive failures and other severe side effects.

Publicidade

Jeronimo Santos é colaborador da redação do Mix Vale, portal de notícias com cobertura de Brasil e mundo. Produz conteúdo nas editorias de economia e benefícios, com foco em informação de serviço para o leitor brasileiro. Escreve para o portal desde 2016: Formação: Marketing

Notícias relacionadas

Mais lidas

  1. Ciência

    Meteoro no Nordeste: bólido cruza o céu de cinco estados às 21h34 e mobiliza buscas por fragmentos na Paraíba

  2. Caixa Econômica Federal

    Pé-de-Meia paga parcela de R$ 1.000,00 a aprovados no ensino médio de 2026 entre fevereiro e março de 2027

  3. Política

    Com obstrução parcial no intestino, Jair Bolsonaro é internado no hospital DF Star em Brasília

  4. INSS

    Recuperação da senha Gov.br pelo celular exige reconhecimento facial ou código por SMS para o Meu INSS

  5. EUA

    Terremoto em Los Angeles atinge magnitude 4,2 e causa tremores leves em Commerce na madrugada

  6. Matéria Publicitária

    MineMV é o novo jogo grátis de construir com blocos; veja como jogar e liberado para todas as idades

  7. Política

    Regulamentação da escala 5×2 pelo governo encarece cálculo da hora extra a partir de 16 de dezembro

  8. Santa Catarina

    Acidente de trânsito na SC-108 envolve carro e moto e deixa motociclista morto em São Ludgero

  9. Mundo

    Jornalista italiano Corrado Augias morre aos 91 anos; presidente da Itália lamenta a perda

  10. Loterias

    Rendimento de R$ 40 milhões da Mega-Sena 3088 chega a R$ 337 mil por mês no Tesouro Direto